2019 Q2 Form 10-Q Financial Statement

#000120179219000010 Filed on August 06, 2019

View on sec.gov

Income Statement

Concept 2019 Q2 2018 Q4 2018 Q2
Revenue $70.56M $76.93M $72.80M
YoY Change -3.07% -1.48% 0.83%
Cost Of Revenue $28.73M $28.44M $28.97M
YoY Change -0.84% -0.73% -2.89%
Gross Profit $41.84M $48.49M $43.83M
YoY Change -4.55% -1.92% 3.47%
Gross Profit Margin 59.29% 63.03% 60.21%
Selling, General & Admin $32.21M $32.71M $30.88M
YoY Change 4.31% 3.35% 0.78%
% of Gross Profit 76.99% 67.46% 70.45%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $3.940M $4.340M $4.350M
YoY Change -9.43% -6.06% -8.03%
% of Gross Profit 9.42% 8.95% 9.92%
Operating Expenses $32.21M $37.06M $30.88M
YoY Change 4.31% 2.21% 0.78%
Operating Profit $5.678M $11.43M $8.048M
YoY Change -29.45% -13.28% 27.38%
Interest Expense $1.135M $990.0K $661.0K
YoY Change 71.71% 607.14% 4306.67%
% of Operating Profit 19.99% 8.66% 8.21%
Other Income/Expense, Net
YoY Change
Pretax Income $6.813M $12.42M $8.709M
YoY Change -21.77% -2.8% 37.52%
Income Tax $1.898M $3.290M $2.280M
% Of Pretax Income 27.86% 26.49% 26.18%
Net Earnings $4.921M $9.093M $6.458M
YoY Change -23.8% 8.03% 68.66%
Net Earnings / Revenue 6.97% 11.82% 8.87%
Basic Earnings Per Share $0.30 $0.55 $0.39
Diluted Earnings Per Share $0.30 $0.55 $0.39
COMMON SHARES
Basic Shares Outstanding 16.51M shares 16.42M shares 16.41M shares
Diluted Shares Outstanding 16.65M shares 16.65M shares

Balance Sheet

Concept 2019 Q2 2018 Q4 2018 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $220.8M $212.1M $193.6M
YoY Change 14.05% 18.36% 23.23%
Cash & Equivalents $220.8M $212.1M $193.6M
Short-Term Investments
Other Short-Term Assets $7.900M $5.500M $6.300M
YoY Change 25.4% 14.58% -12.5%
Inventory
Prepaid Expenses $7.943M $5.482M $6.312M
Receivables $6.413M $14.06M $6.999M
Other Receivables $4.800M $900.0K $3.500M
Total Short-Term Assets $240.0M $232.6M $210.4M
YoY Change 14.06% 21.68% 21.11%
LONG-TERM ASSETS
Property, Plant & Equipment $81.67M $86.88M $87.46M
YoY Change -6.62% -8.79% -6.64%
Goodwill $28.04M $33.90M $33.90M
YoY Change -17.27% 0.0% 0.0%
Intangibles $4.043M
YoY Change -12.22%
Long-Term Investments $5.200M $6.700M $12.30M
YoY Change -57.72% -46.32% -16.17%
Other Assets $5.157M $5.642M $7.706M
YoY Change -33.08% -10.1% -13.89%
Total Long-Term Assets $136.1M $138.4M $141.4M
YoY Change -3.71% -6.43% -6.5%
TOTAL ASSETS
Total Short-Term Assets $240.0M $232.6M $210.4M
Total Long-Term Assets $136.1M $138.4M $141.4M
Total Assets $376.1M $371.0M $351.7M
YoY Change 6.92% 9.41% 8.26%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.923M $9.110M $6.546M
YoY Change -24.79% 3.01% 2.11%
Accrued Expenses $6.763M $3.808M $14.90M
YoY Change -54.6% 5.16% 19.24%
Deferred Revenue $19.05M $18.30M $19.93M
YoY Change -4.41% -5.54%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $42.19M $44.33M $41.38M
YoY Change 1.97% 2.25% 4.21%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $9.200M
YoY Change
Total Long-Term Liabilities $9.200M $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $42.19M $44.33M $41.38M
Total Long-Term Liabilities $9.200M $0.00 $0.00
Total Liabilities $57.63M $49.69M $48.63M
YoY Change 18.51% 0.12% -3.81%
SHAREHOLDERS EQUITY
Retained Earnings $130.3M $133.9M $119.3M
YoY Change 9.2% 23.36% 24.59%
Common Stock $188.1M $187.3M $183.8M
YoY Change 2.38% 3.59% 2.92%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $318.5M $321.3M $303.1M
YoY Change
Total Liabilities & Shareholders Equity $376.1M $371.0M $351.7M
YoY Change 6.92% 9.41% 8.26%

Cashflow Statement

Concept 2019 Q2 2018 Q4 2018 Q2
OPERATING ACTIVITIES
Net Income $4.921M $9.093M $6.458M
YoY Change -23.8% 8.03% 68.66%
Depreciation, Depletion And Amortization $3.940M $4.340M $4.350M
YoY Change -9.43% -6.06% -8.03%
Cash From Operating Activities $15.82M $18.62M $9.330M
YoY Change 69.56% -0.32% -16.84%
INVESTING ACTIVITIES
Capital Expenditures $1.372M -$4.080M $1.893M
YoY Change -27.52% -22.29% -10.33%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change -100.0%
Cash From Investing Activities -$1.370M -$4.080M -$1.890M
YoY Change -27.51% -26.49% 0.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -9.550M 0.000 0.000
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities 15.82M 18.62M 9.330M
Cash From Investing Activities -1.370M -4.080M -1.890M
Cash From Financing Activities -9.550M 0.000 0.000
Net Change In Cash 4.900M 14.54M 7.440M
YoY Change -34.14% 12.36% -20.26%
FREE CASH FLOW
Cash From Operating Activities $15.82M $18.62M $9.330M
Capital Expenditures $1.372M -$4.080M $1.893M
Free Cash Flow $14.45M $22.70M $7.437M
YoY Change 94.27% -5.14% -18.36%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
dei Document Period End Date
DocumentPeriodEndDate
2019-06-30
dei Document Type
DocumentType
10-Q
apei Equity Investment Income Loss After Tax
EquityInvestmentIncomeLossAfterTax
-172000 USD
apei Equity Investment Income Loss After Tax
EquityInvestmentIncomeLossAfterTax
-1481000 USD
apei Increase Decrease In Operating Leases Net
IncreaseDecreaseInOperatingLeasesNet
-364000 USD
CY2019Q2 apei Lessee Operating Lease Liability Payments Due After Year Six
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearSix
2239000 USD
CY2019Q2 apei Lessee Operating Lease Liability Payments Due Year Six
LesseeOperatingLeaseLiabilityPaymentsDueYearSix
566000 USD
apei Number Of Students
NumberOfStudents
81800 student
apei Number Of Subsidiaries
NumberOfSubsidiaries
2 subsidiary
CY2019Q2 apei Operating Lease Additional Right Of Use Asset
OperatingLeaseAdditionalRightOfUseAsset
0 USD
CY2019Q2 apei Percentage Of Students Served In Military On Active Duty At Time Of Initial Enrollment
PercentageOfStudentsServedInMilitaryOnActiveDutyAtTimeOfInitialEnrollment
0.56
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Central Index Key
EntityCentralIndexKey
0001201792
CY2019Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
16047632 shares
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
AMERICAN PUBLIC EDUCATION INC
dei Entity Shell Company
EntityShellCompany
false
dei Entity Small Business
EntitySmallBusiness
false
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
9110000 USD
CY2019Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
4923000 USD
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
14059000 USD
CY2019Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
6413000 USD
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3808000 USD
CY2019Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6763000 USD
CY2018Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
187172000 USD
CY2019Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
187979000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4550000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3319000 USD
CY2018Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1597000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3440000 USD
CY2019Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1630000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3319000 USD
CY2018Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
6648000 USD
CY2019Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
6481000 USD
CY2018Q4 us-gaap Assets
Assets
370958000 USD
CY2019Q2 us-gaap Assets
Assets
376084000 USD
CY2018Q4 us-gaap Assets Current
AssetsCurrent
232570000 USD
CY2019Q2 us-gaap Assets Current
AssetsCurrent
239951000 USD
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2019Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
179205000 USD
CY2018Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
193597000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
212131000 USD
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
220833000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
14392000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
8702000 USD
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
16425000 shares
CY2019Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
16266000 shares
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
16425000 shares
CY2019Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
16266000 shares
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
164000 USD
CY2019Q2 us-gaap Common Stock Value
CommonStockValue
163000 USD
CY2018Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
0 USD
CY2019Q2 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
0 USD
CY2018Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
18310000 USD
CY2019Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
19054000 USD
CY2018Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
28967000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
58653000 USD
CY2019Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
28725000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
56640000 USD
CY2018Q2 us-gaap Costs And Expenses
CostsAndExpenses
64750000 USD
us-gaap Costs And Expenses
CostsAndExpenses
133555000 USD
CY2019Q2 us-gaap Costs And Expenses
CostsAndExpenses
64882000 USD
us-gaap Costs And Expenses
CostsAndExpenses
136941000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
972000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
891000 USD
CY2018Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
5364000 USD
CY2019Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
6255000 USD
CY2018Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
4347000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
8869000 USD
CY2019Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
3943000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
7994000 USD
CY2018Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.39
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.67
CY2019Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.30
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.36
CY2018Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.39
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.67
CY2019Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.30
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
36482000 USD
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-130000 USD
CY2018Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
17594000 USD
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.36
CY2018Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
13100000 USD
CY2019Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
9488000 USD
CY2018Q4 us-gaap Equity Method Investments
EquityMethodInvestments
6700000 USD
CY2019Q2 us-gaap Equity Method Investments
EquityMethodInvestments
5200000 USD
CY2018Q2 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-558000 USD
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-686000 USD
CY2019Q2 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-4000 USD
CY2019Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
18123000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
37188000 USD
CY2018Q4 us-gaap Goodwill
Goodwill
33899000 USD
CY2019Q2 us-gaap Goodwill
Goodwill
28044000 USD
CY2018Q2 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2019Q2 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
5855000 USD
CY2019Q1 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0 USD
CY2018Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
8709000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
15364000 USD
CY2019Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
6813000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
9248000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
4809000 USD
CY2018Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
29000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-172000 USD
CY2019Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
6000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1481000 USD
CY2018Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2280000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4145000 USD
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1898000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1835000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
5409000 USD
CY2018Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
898000 USD
CY2019Q2 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
4762000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2298000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-4187000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-137000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-7646000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1366000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
3080000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
282000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
744000 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
874000 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-3612000 USD
us-gaap Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
-5166000 USD
us-gaap Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
-3864000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-345000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-292000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1419000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2407000 USD
CY2018Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
238000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
227000 shares
CY2019Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
141000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
149000 shares
CY2018Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
661000 USD
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
1154000 USD
CY2019Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
1135000 USD
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
2188000 USD
CY2018Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
11966000 USD
CY2019Q2 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
10485000 USD
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
13098000 USD
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1800000 USD
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
1523000 USD
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
2481000 USD
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
2537000 USD
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
2517000 USD
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
1235000 USD
CY2019Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1953000 USD
CY2019Q2 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P5Y
CY2019Q2 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P62M
CY2018Q4 us-gaap Liabilities
Liabilities
49692000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2957000 USD
CY2019Q2 us-gaap Liabilities
Liabilities
57628000 USD
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
370958000 USD
CY2019Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
376084000 USD
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
44328000 USD
CY2019Q2 us-gaap Liabilities Current
LiabilitiesCurrent
42191000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1615000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-12061000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3559000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
19566000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
23720000 USD
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
6458000 USD
us-gaap Net Income Loss
NetIncomeLoss
11047000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
4921000 USD
us-gaap Net Income Loss
NetIncomeLoss
5932000 USD
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 segment
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
CY2018Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
8048000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
14210000 USD
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
5678000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
7060000 USD
CY2019Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
600000 USD
us-gaap Operating Lease Expense
OperatingLeaseExpense
1200000 USD
CY2019Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
11145000 USD
CY2019Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1963000 USD
CY2019Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
9182000 USD
CY2019Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
600000 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
1200000 USD
CY2019Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
10781000 USD
CY2019Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
11800000 USD
CY2019Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.051
CY2019Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y0M6D
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
5642000 USD
CY2019Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
5157000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-259000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-62000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1615000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
12061000 USD
CY2018Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1893000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3559000 USD
CY2019Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1372000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2957000 USD
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2019Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2019Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2018Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2019Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
86881000 USD
CY2019Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
81666000 USD
CY2018Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
1700000 USD
CY2019Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
1700000 USD
CY2018Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2019Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2018Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2019Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2018Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
5482000 USD
CY2019Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
7943000 USD
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
133930000 USD
CY2019Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
130314000 USD
CY2018Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
72798000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
147765000 USD
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
70560000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
144001000 USD
CY2018Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
13284000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
28865000 USD
CY2019Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
14087000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
29134000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
3440000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
3319000 USD
us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
0 USD
us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
0 USD
us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
9551000 USD
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
1616000 USD
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
2510000 USD
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
289406000 USD
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
303109000 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
321266000 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
318456000 USD
CY2018Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16646000 shares
CY2018Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16645863 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16611000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16611177 shares
CY2019Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16652544 shares
CY2019Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16653000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16671405 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16671000 shares
CY2018Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16408408 shares
CY2018Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16408000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16384000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16384234 shares
CY2019Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16512000 shares
CY2019Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16511522 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16522000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16522304 shares
us-gaap Nature Of Operations
NatureOfOperations
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Nature of the Business</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">American Public Education, Inc., or APEI, which together with its subsidiaries is referred to as the &#8220;Company,&#8221; is a provider of online and campus-based postsecondary education to approximately </font><font style="font-family:inherit;font-size:10pt;">81,800</font><font style="font-family:inherit;font-size:10pt;"> students through </font><font style="font-family:inherit;font-size:10pt;">two</font><font style="font-family:inherit;font-size:10pt;"> subsidiary institutions:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">American Public University System, Inc., or APUS, provides online postsecondary education directed primarily at the needs of the military, military-affiliated, and public service communities through American Military University, or AMU, and American Public University, or APU.&#160;APUS is regionally accredited by the Higher Learning Commission and several of its academic programs have specialized accreditation granted by industry-governing organizations.</font></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">National Education Seminars, Inc., which is referred to herein as Hondros College of Nursing, or HCN,&#160;provides nursing education to students at </font><font style="font-family:inherit;font-size:10pt;">five</font><font style="font-family:inherit;font-size:10pt;"> campuses in Ohio to serve the needs of the nursing and healthcare communities. HCN is nationally accredited by the Accrediting Bureau for Health Education Schools, or ABHES.</font></div></td></tr></table><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company&#8217;s institutions are licensed or otherwise authorized, or are in the process of obtaining such licenses or authorizations, to offer postsecondary education programs by state authorities to the extent the institutions believe such licenses or authorizations are required, and are certified by the United States Department of Education, or ED, to participate in student financial aid programs authorized under Title IV of the Higher Education Act of 1965, as amended, or Title IV programs.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company&#8217;s operations are organized into </font><font style="font-family:inherit;font-size:10pt;">two</font><font style="font-family:inherit;font-size:10pt;"> reportable segments:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">American Public Education Segment, </font><font style="font-family:inherit;font-size:10pt;">or</font><font style="font-family:inherit;font-size:10pt;font-style:italic;"> APEI Segment.</font><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"> </font><font style="font-family:inherit;font-size:10pt;">This segment reflects the operational activities at APUS, other corporate activities, and minority investments.</font></div></td></tr></table><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Hondros College of Nursing Segment, </font><font style="font-family:inherit;font-size:10pt;">or</font><font style="font-family:inherit;font-size:10pt;font-style:italic;"> HCN Segment.</font><font style="font-family:inherit;font-size:10pt;">&#160;This segment reflects the operational activities of HCN.</font></div></td></tr></table></div>
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In preparing financial statements in conformity with GAAP, the Company is required to make estimates and judgments that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting period. The Company evaluates these estimates and judgments on an ongoing basis and bases its estimates on experience, current and expected future conditions, and various other assumptions that the Company believes are reasonable under the circumstances. Actual results may differ from these estimates.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div>

Files In Submission

Name View Source Status
0001201792-19-000010-index-headers.html Edgar Link pending
0001201792-19-000010-index.html Edgar Link pending
0001201792-19-000010.txt Edgar Link pending
0001201792-19-000010-xbrl.zip Edgar Link pending
apei-20190630.xml Edgar Link completed
apei-20190630.xsd Edgar Link pending
apei-20190630_cal.xml Edgar Link unprocessable
apei-20190630_def.xml Edgar Link unprocessable
apei-20190630_lab.xml Edgar Link unprocessable
apei-20190630_pre.xml Edgar Link unprocessable
apeiq20630201910q.htm Edgar Link pending
exhibit311_q219.htm Edgar Link pending
exhibit312_q219.htm Edgar Link pending
exhibit321_q219.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
image0a15.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
R9999.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending